Australia, Sept. 26 -- GlaxoSmithKline Biologicals SA, owns the trademark (2522766) for 'FLUPEMI' till Feb. 17, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical and medicinal preparations and substances; vaccines]
Type of Mark: Word
Date of Acceptance: April 24
Registration Advertised: Sept. 25
For further details contact Davies Collison Cave Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2522766.
Disclaimer: Curated by HT Syndication.
